→ Turns out IDO is not dead yet. Kyowa Hakko Kirin has announced that it is testing its
November 2, 2018 11:48 AM EDT News Briefing Kyowa Hakko Kirin gears up to test IDO/PD-1 combo; AbbVie fights Humira biosimilars with 80% price cut in Europe Amber Tong → Turns out IDO is not dead yet. Kyowa Hakko Kirin has announced that it is testing its Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
